NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

NASDAQ · Medical Care Facilities · USD

AirSculpt Technologies, Inc. (AIRS) Stock Analysis

AirSculpt Technologies, Inc. (AIRS) is a Medical Care Facilities stock listed on NASDAQ and quoted in US Dollar.

AIRS

$2.80

+$0.25 (+10.04%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare AIRS with… →

AIRS Key Statistics

As of Sep 4, 2026
Trading
Open
$2.51
Previous Close
$2.54
Day's Range
2.51–2.88
52-Week Range
1.51–12.00
Volume
1.59M
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
2.29
Valuation
Market Cap
$201.51M
P/E Ratio
unprofitable
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
1.34
EPS (ttm)Profit attributable to each share over the last twelve months.
−0.20
Financials (FY)
Revenue (FY)
$151.82M−15.82%
Net Income (FY)
−$11.67M
Profit marginThe share of revenue left as profit after all costs and taxes.
−7.79%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
72.10M
1-Year Return
−52.63%
Dividend and dates
Earnings Date
November 9, 2026
Avg Volume
694.74K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

AIRS Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+41.16%
2025−61.85%
2024−30.71%
2023+102.43%
2022−77.55%
2021 (partial year)+8.18%

As of September 4, 2026.

AIRS Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$151.82M−$11.67M−7.7%
2024$180.35M−$8.02M−4.4%
2023$195.92M−$4.24M−2.2%
2022$168.79M−$14.68M−8.7%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$151.82M$90.13M−$4.83M−$11.67M−7.7%
2024$180.35M$109.20M−$1.57M−$8.02M−4.4%
2023$195.92M$122.14M$9.51M−$4.24M−2.2%
2022$168.79M$106.01M−$3.47M−$14.68M−8.7%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

AIRS Valuation vs Medical Care Facilities Median

Median of 57 stocks
MetricAIRSMedical Care Facilities medianvs median
P/S ratio1.340.9541% above
Profit margin−7.79%3.06%10.8 pts below

Medians across 57 Medical Care Facilities stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

The market values AirSculpt Technologies, Inc. (AIRS) at $201.51M. The company sits in the Healthcare sector, in the Medical Care Facilities industry. Headcount on file is 330.

AIRS last closed at $2.80 on September 4, 2026. That is +$0.25 (+10.04%) against the previous close. Over the past 52 weeks the price has ranged from $1.51 to $12.00. The latest close sits 85.1% above that 52-week low.

Financial Health

In fiscal 2025, AirSculpt Technologies, Inc. reported revenue of $151.82M. Against the prior fiscal year total of $180.35M, that is a change of −15.82%. The same year closed with a net loss of $11.67M. Profit margin runs at −7.79%. That is 10.8 percentage points below the Medical Care Facilities median of 3.06%. Earnings per share on a trailing basis come to −0.2.

Across the 4 fiscal years on file, revenue moves from $168.79M in 2022 to $151.82M in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

No trailing P/E applies: the last reported earnings figure is negative. Measured against sales, the shares trade at 1.34 times revenue. On price-to-sales that is 40.66% above the Medical Care Facilities median of 0.95. The medians here are taken across 57 Medical Care Facilities companies that report the metric.

Over the trailing twelve months the price has returned −52.63%. Measured over 3 years, that is −28.45% a year compounded. The reported beta is 2.29. Annualized volatility over the trailing 4 years is 98.63%.

Growth & Income

The record shows no dividend for AIRS.

Across the complete calendar years on file, 2023 returned +102.43% and 2022 returned −77.55%. Of the 4 complete calendar years on file, 1 finished higher. So far in 2026 the price is +41.16%.

Peer Comparison

AirSculpt Technologies, Inc. (AIRS) operates in the Medical Care Facilities industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
AirSculpt Technologies, Inc. AIRS $201.51M —
HCA Healthcare, Inc. HCA $87.68B 13.6
Tenet Healthcare Corporation THC $21.34B 10.2
Fresenius Medical Care AG FMS $12.06B 11.7

The Medical Care Facilities industry average P/E ratio is 19.8x. AirSculpt Technologies, Inc. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Medical Care Facilities Stocks

HCA

HCA Healthcare, Inc.

$87.68B

 THC

Tenet Healthcare Corporation

$21.34B

 FMS

Fresenius Medical Care AG

$12.06B

 EHC

Encompass Health Corporation

$12.01B

 DVA

DaVita Inc.

$11.74B

 UHS

Universal Health Services, Inc.

$10.00B
View all Medical Care Facilities stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.02T

 JNJ

Johnson & Johnson

$663.28B

 ABBV

AbbVie Inc.

$453.19B

 MRK

Merck & Co., Inc.

$370.89B

 UNH

UnitedHealth Group Incorporated

$356.47B
View all Healthcare stocks →

About AirSculpt Technologies, Inc.

AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States and Canada. The company offers AirSculpt, a body contouring treatment that removes fat and tightens skin while sculpting targeted areas of the body in a minimally invasive procedure. It also provides AirSculpt+, a procedure that permanently removes fat and tightens the skin with unparalleled precision and finesse; and AirSculpt Smooth, an advanced cellulite removal tool. In addition, it provides fat removal procedures across treatment areas, such as the stomach, back, and buttocks; and fat transfer procedures that transfers the patient's own fat cells to enhance the buttocks, breasts, hips, aging hands, or other areas. Further, the company's body contouring procedures include the Power BBL, a Brazilian butt lift procedure; the Up a Cup, a breast enhancement procedure; and the Hip Flip, an hourglass contouring procedure. Additionally, it operates various centers. The company was founded in 2012 and is headquartered in Tampa, Florida.

Visit website →